{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:00:37Z","timestamp":1793145637386,"version":"4.5.0"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01AI136033"],"award-info":[{"award-number":["U01AI136033"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Civilian Research & Development Foundation","award":["DAA3-19-65623"],"award-info":[{"award-number":["DAA3-19-65623"]}],"id":[{"id":"https:\/\/ror.org\/01zpbb709","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s40121-022-00602-2","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T08:02:44Z","timestamp":1645516964000},"page":"695-711","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Treatment of Cutaneous Leishmaniasis and Insights into Species-Specific Responses: A Narrative Review"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8793-0862","authenticated-orcid":false,"given":"Rajamanthrilage Kasun","family":"Madusanka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2288-1294","authenticated-orcid":false,"given":"Hermali","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3985-1817","authenticated-orcid":false,"given":"Nadira D.","family":"Karunaweera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,22]]},"reference":[{"issue":"3","key":"602_CR1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0738-081X(99)00046-2","volume":"17","author":"R Killick-Kendrick","year":"1999","unstructured":"Killick-Kendrick R. The biology and control of Phlebotomine sand flies. Clin Dermatol. 1999;17(3):279\u201389.","journal-title":"Clin Dermatol"},{"key":"602_CR2","unstructured":"World Health Organization. Control of the leishmaniases: Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases,Geneva, 22\u201326 March 2010. 2010. https:\/\/apps.who.int\/iris\/handle\/10665\/44412. Accessed 9 May 2021."},{"issue":"5","key":"602_CR3","doi-asserted-by":"crossref","first-page":"35671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J, V\u00e9lez ID, Bern C, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS\u00a0One. 2012;7(5):35671.","journal-title":"PLoS\u00a0One"},{"issue":"12","key":"602_CR4","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.pt.2006.09.004","volume":"22","author":"J Alvar","year":"2006","unstructured":"Alvar J, Yactayo S, Bern C. Leishmaniasis and poverty. Trends Parasitol. 2006;22(12):552\u20137.","journal-title":"Trends Parasitol"},{"issue":"10151","key":"602_CR5","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","volume":"392","author":"S Burza","year":"2018","unstructured":"Burza S, Croft SL, Boelaert M. Leishmaniasis. Lancet. 2018;392(10151):951\u201370.","journal-title":"Lancet"},{"issue":"3","key":"602_CR6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.det.2015.03.018","volume":"33","author":"I Kevric","year":"2015","unstructured":"Kevric I, Cappel MA, Keeling JH. New World and Old World Leishmania infections: a practical review. Dermatol Clin. 2015;33(3):579\u201393.","journal-title":"Dermatol Clin"},{"issue":"9","key":"602_CR7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","volume":"7","author":"R Reithinger","year":"2007","unstructured":"Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis. 2007;7(9):581\u201396.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"602_CR8","first-page":"319","volume":"89","author":"JML Costa","year":"1986","unstructured":"Costa JML, Marsden PD, Llanos-Cuentas EA, et al. Disseminated cutaneous leishmaniasis in a field clinic in Bahia, Brazil: a report of eight cases. J Trop Med Hyg. 1986;89(6):319\u201323.","journal-title":"J Trop Med Hyg"},{"issue":"4","key":"602_CR9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0001-706X(94)90103-1","volume":"56","author":"EM Carvalho","year":"1994","unstructured":"Carvalho EM, Barral A, Costa JML, Bittencourt A, Marsden P. Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis. Acta Trop. 1994;56(4):315\u201325. Accessed 9 May 2021.","journal-title":"Acta Trop"},{"key":"602_CR10","unstructured":"Pan American Health Organization, World Health Organization. Leishmaniasis in the Americas: treatment recommendation. 2015. http:\/\/iris.paho.org\/xmlui\/bitstream\/handle\/123456789\/7704\/9789275117521_eng.pdf?sequence=5&isAllowed=y. Accessed 9 May 2021."},{"key":"602_CR11","unstructured":"WHO. Leishmaniasis. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/leishmaniasis. Accessed 9 May 2021."},{"issue":"5","key":"602_CR12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0190-9622(94)70229-2","volume":"31","author":"AB Koff","year":"1994","unstructured":"Koff AB, Rosen T. Treatment of cutaneous leishmaniasis. J Am Acad Dermatol. 1994;31(5):693\u2013708.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"602_CR13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0738-081X(96)00057-0","volume":"14","author":"P Desjeux","year":"1996","unstructured":"Desjeux P. Leishmaniasis: public health aspects and control. Clin Dermatol. 1996;14(5):417\u201323.","journal-title":"Clin Dermatol"},{"key":"602_CR14","doi-asserted-by":"crossref","unstructured":"Modabber F, Buffet PA, Torreele E, Milon G, Croft SL. Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13\u201315 June, 2006. Kinetoplastid Biol Dis. 2007;6:3.","DOI":"10.1186\/1475-9292-6-3"},{"issue":"6","key":"602_CR15","doi-asserted-by":"crossref","first-page":"0936","DOI":"10.1371\/journal.pmed.0030283","volume":"3","author":"L Savioli","year":"2006","unstructured":"Savioli L, Engels D, Daumerie D, et al. Response from Savioli and colleagues from the Department of Neglected Tropical Diseases, World Health Organization. PLoS Med. 2006;3(6):0936\u20138.","journal-title":"PLoS Med"},{"issue":"4","key":"602_CR16","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/clind\/24.4.684","volume":"24","author":"JD Berman","year":"1997","unstructured":"Berman JD. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis. 1997;24(4):684\u2013703.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"602_CR17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jaad.2007.12.032","volume":"58","author":"IM Mosleh","year":"2008","unstructured":"Mosleh IM, Geith E, Natsheh L, Sch\u00f6nian G, Abotteen N, Kharabsheh S. Efficacy of a weekly cryotherapy regimen to treat Leishmania major cutaneous leishmaniasis. J Am Acad Dermatol. 2008;58(4):617\u201324.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"602_CR18","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4269\/ajtmh.20-0855","volume":"104","author":"H Silva","year":"2021","unstructured":"Silva H, Liyanage A, Deerasinghe T, et al. Therapeutic response to thermotherapy in cutaneous leishmaniasis treatment failures for sodium stibogluconate: a randomized controlled proof of principle clinical trial. Am J Trop Med Hyg. 2021;104(3):945\u201350.","journal-title":"Am J Trop Med Hyg"},{"key":"602_CR19","doi-asserted-by":"publisher","unstructured":"Oliveira RM de, Melo S de A, Penha-Silva TA da, Almeida-Souza F, Abreu-Silva AL. Alternative treatment for leishmaniasis. In: Leishmaniases as Re-emerging Diseases. InTech; 2018. https:\/\/doi.org\/10.5772\/intechopen.75895.","DOI":"10.5772\/intechopen.75895"},{"key":"602_CR20","doi-asserted-by":"crossref","unstructured":"Berbert TRN, Mello TFP De, Wolf Nassif P, et al. Pentavalent antimonials combined with other therapeutic alternatives for the treatment of cutaneous and mucocutaneous leishmaniasis: a systematic review. Dermatol Res Pract. 2018;2018:9014726.","DOI":"10.1155\/2018\/9014726"},{"issue":"3","key":"602_CR21","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/infdis\/165.3.528","volume":"165","author":"TR Navin","year":"1992","unstructured":"Navin TR, Arana BA, Arana FE, Berman JD, Chaj\u00f3n JF. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. J Infect Dis. 1992;165(3):528\u201334.","journal-title":"J Infect Dis"},{"issue":"12","key":"602_CR22","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1086\/518041","volume":"195","author":"J Arevalo","year":"2007","unstructured":"Arevalo J, Ramirez L, Adaui V, et al. Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis. J Infect Dis. 2007;195(12):1846\u201351.","journal-title":"J Infect Dis"},{"issue":"2","key":"602_CR23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/0974-777X.62886","volume":"2","author":"S Sundar","year":"2010","unstructured":"Sundar S, Jaya J. Liposomal amphotericin\u00a0B and leishmaniasis: dose and response. J Glob Infect Dis. 2010;2(2):159.","journal-title":"J Glob Infect Dis"},{"issue":"11","key":"602_CR24","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1346-8138.2011.01270.x","volume":"38","author":"M Ono","year":"2011","unstructured":"Ono M, Takahashi K, Taira K, Uezato H, Takamura S, Izaki S. Cutaneous leishmaniasis in a Japanese returnee from West Africa successfully treated with liposomal amphotericin\u00a0B. J Dermatol. 2011;38(11):1062\u20135.","journal-title":"J Dermatol"},{"issue":"2","key":"602_CR25","doi-asserted-by":"crossref","first-page":"495","DOI":"10.12669\/pjms.35.2.54","volume":"35","author":"M Tahir","year":"2019","unstructured":"Tahir M, Bashir U, Hafeez J, Ghafoor R. Safety and efficacy of miltefosine in cutaneous leishmaniasis: an open label, non-comparative study from Balochistan. Pak J Med Sci. 2019;35(2):495\u20139.","journal-title":"Pak J Med Sci"},{"issue":"9","key":"602_CR26","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/383321","volume":"38","author":"J Soto","year":"2004","unstructured":"Soto J, Arana BA, Tolado J, et al. Miltefosine for new world cutaneous leishmaniasis. Clin Infect Dis. 2004;38(9):1266\u201372.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"602_CR27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0035-9203(94)90517-7","volume":"88","author":"G Krause","year":"1994","unstructured":"Krause G, Kroeger A. Topical treatment of American cutaneous leishmaniasis with paramomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador. Trans R Soc Trop Med Hyg. 1994;88(1):92\u20134.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"602_CR28","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2230.2006.02182.x","volume":"31","author":"A Asilian","year":"2006","unstructured":"Asilian A, Davami M. Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial. Clin Exp Dermatol. 2006;31(5):634\u20137.","journal-title":"Clin Exp Dermatol"},{"issue":"10","key":"602_CR29","doi-asserted-by":"crossref","first-page":"e0186117","DOI":"10.1371\/journal.pone.0186117","volume":"12","author":"EL Galv\u00e3o","year":"2017","unstructured":"Galv\u00e3o EL, Rabello A, Cota GF. Efficacy of azole therapy for tegumentary leishmaniasis: a systematic review and meta-analysis. PLoS\u00a0One. 2017;12(10):e0186117.","journal-title":"PLoS\u00a0One"},{"issue":"2","key":"602_CR30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0002-9343(90)90292-L","volume":"89","author":"RE Saenz","year":"1990","unstructured":"Saenz RE, Paz H, Berman JD. Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis. Am J Med. 1990;89(2):147\u201355.","journal-title":"Am J Med"},{"key":"602_CR31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tmaid.2018.02.010","volume":"24","author":"JR Christen","year":"2018","unstructured":"Christen JR, Bourreau E, Demar M, et al. Use of the intramuscular route to administer pentamidine isethionate in Leishmania guyanensis cutaneous leishmaniasis increases the risk of treatment failure. Travel Med Infect Dis. 2018;24:31\u20136.","journal-title":"Travel Med Infect Dis"},{"issue":"2","key":"602_CR32","doi-asserted-by":"crossref","first-page":"e0006225","DOI":"10.1371\/journal.pntd.0006225","volume":"12","author":"VA Francesconi","year":"2018","unstructured":"Francesconi VA, Francesconi F, Ramasawmy R, Romero GAS, Alecrim MGC. Failure of fluconazole in treating cutaneous leishmaniasis caused by Leishmania guyanensis in the Brazilian Amazon: an open, nonrandomized phase 2 trial. PLoS Negl Trop Dis. 2018;12(2):e0006225.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"602_CR33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.actatropica.2011.02.007","volume":"118","author":"LF Oliveira","year":"2011","unstructured":"Oliveira LF, Schubach AO, Martins MM, et al. Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World. Acta Trop. 2011;118(2):87\u201396.","journal-title":"Acta Trop"},{"issue":"2","key":"602_CR34","doi-asserted-by":"crossref","first-page":"e0003500","DOI":"10.1371\/journal.pntd.0003500","volume":"9","author":"G Mandal","year":"2015","unstructured":"Mandal G, Mandal S, Sharma M, et al. Species-specific antimonial sensitivity in Leishmania is driven by post-transcriptional regulation of AQP1. PLoS Negl Trop Dis. 2015;9(2):e0003500.","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"602_CR35","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.bbagen.2008.03.006","volume":"1780","author":"RL Krauth-Siegel","year":"2008","unstructured":"Krauth-Siegel RL, Comini MA. Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism. Biochim Biophys Acta. 2008;1780(11):1236\u201348.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"602_CR36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0006-291X(88)80081-0","volume":"152","author":"AK Chakraborty","year":"1988","unstructured":"Chakraborty AK, Majumder HK. Mode of action of pentavalent antimonials: specific inhibition of type I DNA topoisomerase of Leishmania donovani. Biochem Biophys Res Commun. 1988;152(2):605\u201311.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"602_CR37","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1645\/GE-3347","volume":"90","author":"J Walker","year":"2004","unstructured":"Walker J, Saravia NG. Inhibition of Leishmania donovani promastigote DNA topoisomerase I and human monocyte DNA topoisomerases I and II by antimonial drugs and classical antitopoisomerase agents. J Parasitol. 2004;90(5):1155\u201362.","journal-title":"J Parasitol"},{"issue":"6","key":"602_CR38","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1128\/AAC.27.6.916","volume":"27","author":"JD Berman","year":"1985","unstructured":"Berman JD, Waddel D, Hanson BD. Biochemical mechanisms of the antileishmanial activity of sodium stibogluconate. Antimicrob Agents Chemother. 1985;27(6):916\u201320.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"602_CR39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0006-2952(87)90689-7","volume":"36","author":"JD Herman","year":"1987","unstructured":"Herman JD, Gallalee JV, Best JM. Sodium stibogluconate (Pentostam) inhibition of glucose catabolism via the glycolytic pathway, and fatty acid \u03b2-oxidation in Leishmania mexicana amastigotes. Biochem Pharmacol. 1987;36(2):197\u2013201.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"602_CR40","doi-asserted-by":"crossref","first-page":"e1514","DOI":"10.1371\/journal.pntd.0001514","volume":"6","author":"S Decuypere","year":"2012","unstructured":"Decuypere S, Vanaerschot M, Brunker K, et al. Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background. PLoS Negl Trop Dis. 2012;6(2):e1514.","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"602_CR41","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4269\/ajtmh.2001.65.456","volume":"65","author":"GAS Romero","year":"2001","unstructured":"Romero GAS, De Farias GMV, Paes MG, De Oliveira MV. Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V) guyanensis in Brazil: therapeutic response to meglumine antimoniate. Am J Trop Med Hyg. 2001;65(5):456\u201365.","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"602_CR42","doi-asserted-by":"crossref","first-page":"e0004495","DOI":"10.1371\/journal.pntd.0004495","volume":"10","author":"J van Griensven","year":"2016","unstructured":"van Griensven J, Gadisa E, Aseffa A, Hailu A, Beshah AM, Diro E. Treatment of cutaneous leishmaniasis caused by Leishmania aethiopica: a systematic review. PLoS Negl Trop Dis. 2016;10(3):e0004495.","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"602_CR43","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/jac\/35.5.577","volume":"35","author":"RA Neal","year":"1995","unstructured":"Neal RA, Allen S, Mccoy N, Olliaro P, Croft SL. The sensitivity of Leishmania species to aminosidine. J Antimicrob Chemother. 1995;35(5):577\u201384.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"602_CR44","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3109\/10715762.2012.668186","volume":"46","author":"A Sarkar","year":"2012","unstructured":"Sarkar A, Ghosh S, Pakrashi S, Roy D, Sen S, Chatterjee M. Leishmania strains causing self-healing cutaneous leishmaniasis have greater susceptibility towards oxidative stress. Free Radic Res. 2012;46(5):665\u201373.","journal-title":"Free Radic Res"},{"issue":"8","key":"602_CR45","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1086\/428736","volume":"40","author":"R Reithinger","year":"2005","unstructured":"Reithinger R, Mohsen M, Wahid M, et al. Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial. Clin Infect Dis. 2005;40(8):1148\u201355.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"602_CR46","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1086\/341406","volume":"35","author":"G Wortmann","year":"2002","unstructured":"Wortmann G, Miller RS, Oster C, Jackson J, Aronson N. A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel. Clin Infect Dis. 2002;35(3):261\u20137.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"602_CR47","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/clinids\/18.3.381","volume":"18","author":"BA Arana","year":"1994","unstructured":"Arana BA, Navin TR, Arana FE, Berman JD, Rosenkaimer F. Efficacy of a short course (10 days) of high-dose meglumine antimonate with or without interferon-gamma in treating cutaneous leishmaniasis in Guatemala. Clin Infect Dis. 1994;18(3):381\u20134.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"602_CR48","doi-asserted-by":"crossref","first-page":"e628","DOI":"10.1371\/journal.pntd.0000628","volume":"4","author":"NE Aronson","year":"2010","unstructured":"Aronson NE, Wortmann GW, Byrne WR, et al. A randomized controlled trial of local heat therapy versus intravenous sodium stibogluconate for the treatment of cutaneous Leishmania major infection. PLoS Negl Trop Dis. 2010;4(3):e628.","journal-title":"PLoS Negl Trop Dis"},{"issue":"8549","key":"602_CR49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(87)93053-4","volume":"330","author":"WR Ballou","year":"1987","unstructured":"Ballou WR, Gordon DM, Andujar J, et al. Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis. Lancet. 1987;330(8549):13\u20136.","journal-title":"Lancet"},{"issue":"6","key":"602_CR50","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/0190-9622(93)70275-X","volume":"29","author":"H Sindermann","year":"1993","unstructured":"Sindermann H, Krasovec M, Burg G. Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: results of a phase I\/II study. J Am Acad Dermatol. 1993;29(6):963\u201370.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"602_CR51","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00430-003-0201-2","volume":"193","author":"H Sindermann","year":"2004","unstructured":"Sindermann H, Croft SL, Engel KR, et al. Miltefosine (Impavido): the first oral treatment against leishmaniasis. Med Microbiol Immunol. 2004;193(4):173\u201380.","journal-title":"Med Microbiol Immunol"},{"issue":"6","key":"602_CR52","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/j.1365-2133.2007.07872.x","volume":"156","author":"O Zerpa","year":"2007","unstructured":"Zerpa O, Ulrich M, Blanco B, et al. Diffuse cutaneous leishmaniasis responds to miltefosine but then relapses. Br J Dermatol. 2007;156(6):1328\u201335.","journal-title":"Br J Dermatol"},{"issue":"17","key":"602_CR53","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s40265-013-0132-1","volume":"73","author":"B Monge-Maillo","year":"2013","unstructured":"Monge-Maillo B, L\u00f3pez-V\u00e9lez R. Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis. Drugs. 2013;73(17):1889\u2013920.","journal-title":"Drugs"},{"issue":"7","key":"602_CR54","doi-asserted-by":"crossref","first-page":"E57","DOI":"10.1086\/322689","volume":"33","author":"J Soto","year":"2001","unstructured":"Soto J, Toledo J, Gutierrez P, et al. Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent. Clin Infect Dis. 2001;33(7):E57-61.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"602_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0000912","volume":"4","author":"PR Machado","year":"2010","unstructured":"Machado PR, Ampuero J, Guimar\u00e3es LH, et al. Miltefosine in the treatment of cutaneous leishmaniasis caused by leishmania braziliensis in Brazil: a randomized and controlled trial. PLoS Negl Trop Dis. 2010;4(12):1\u20136.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"602_CR56","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4269\/ajtmh.2011.10-0155","volume":"84","author":"A Chrusciak-Talhari","year":"2011","unstructured":"Chrusciak-Talhari A, Dietze R, Talhari CC, et al. Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania (Viannia) guyanensis in Manaus, Brazil. Am J Trop Med Hyg. 2011;84(2):255\u201360.","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"602_CR57","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1086\/510588","volume":"44","author":"J Soto","year":"2007","unstructured":"Soto J, Tolado J, Valda L, et al. Treatment of Bolivian mucosal leishmaniasis with miltefosine. Clin Infect Dis. 2007;44(3):350\u20136.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"602_CR58","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.actatropica.2007.05.005","volume":"103","author":"M Mohebali","year":"2007","unstructured":"Mohebali M, Fotouhi A, Hooshmand B, et al. Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran. Acta Trop. 2007;103(1):33\u201340.","journal-title":"Acta Trop"},{"issue":"5","key":"602_CR59","first-page":"353","volume":"81","author":"A Asilian","year":"2003","unstructured":"Asilian A, Jalayer T, Nilforooshzadeh M, et al. Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran. Bull World Health Organ. 2003;81(5):353\u20139.","journal-title":"Bull World Health Organ"},{"issue":"2","key":"602_CR60","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2307\/3285646","volume":"85","author":"M Grogl","year":"1999","unstructured":"Grogl M, Schuster BG, Ellis WY, Berman JD. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (aminosidine) and gentamicin. J Parasitol. 1999;85(2):354\u20139.","journal-title":"J Parasitol"},{"issue":"1","key":"602_CR61","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/AAC.00506-10","volume":"55","author":"MM Fern\u00e1ndez","year":"2011","unstructured":"Fern\u00e1ndez MM, Malchiodi EL, Algranati ID. Differential effects of paromomycin on ribosomes of Leishmania Mexicana and mammalian cells. Antimicrob Agents Chemother. 2011;55(1):86\u201393.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"602_CR62","doi-asserted-by":"crossref","first-page":"e26660","DOI":"10.1371\/journal.pone.0026660","volume":"6","author":"B Chawla","year":"2011","unstructured":"Chawla B, Jhingran A, Panigrahi A, Stuart KD, Madhubala R. Paromomycin affects translation and vesicle-mediated trafficking as revealed by proteomics of paromomycin-susceptible-resistant Leishmania donovani. PLoS\u00a0One. 2011;6(10):e26660.","journal-title":"PLoS\u00a0One"},{"key":"602_CR63","unstructured":"World Health Organization. Cutaneous and Mucosal Leishmaniasis Pan American Health Organization. WHO Pan American Health Organization. 2020. https:\/\/www.paho.org\/en\/topics\/leishmaniasis\/cutaneous-and-mucosal-leishmaniasis. Accessed 10 Jun 2021."},{"issue":"6","key":"602_CR64","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0035-9203(94)90235-6","volume":"88","author":"J Soto","year":"1994","unstructured":"Soto J, Grog M, Berman J, Olliaro P. Limited efficacy of injectable aminosidine as single-agent therapy for Colombian cutaneous leishmaniasis. Trans R Soc Trop Med Hyg. 1994;88(6):695\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"602_CR65","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/0035-9203(94)90237-2","volume":"88","author":"NC Hepburn","year":"1994","unstructured":"Hepburn NC, Tidman MJ, Hunter JAA. Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg. 1994;88(6):700\u20133.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6497","key":"602_CR66","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/bmj.291.6497.704","volume":"291","author":"J El-On","year":"1985","unstructured":"El-On J, Even-Paz Z, Livshin R, Weinrauch L, Jacobs GP. Topical treatment of recurrent cutaneous leishmaniasis with ointment containing paromomycin and methylbenzethonium chloride. Br Med J (Clin Res Ed). 1985;291(6497):704\u20135.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"5","key":"602_CR67","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4269\/ajtmh.2001.65.466","volume":"65","author":"BA Arana","year":"2001","unstructured":"Arana BA, Mendoza CE, Rizzo NR, Kroeger A. Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala. Am J Trop Med Hyg. 2001;65(5):466\u201370.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"602_CR68","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0190-9622(92)70175-F","volume":"27","author":"J El-On","year":"1992","unstructured":"El-On J, Halevy S, Grunwald MH, Weinrauch L. Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study. J Am Acad Dermatol. 1992;27(2):227\u201331.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"602_CR69","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1365-4362.1997.00022.x","volume":"36","author":"O Ozgoztasi","year":"1997","unstructured":"Ozgoztasi O, Baydar I. A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey. Int J Dermatol. 1997;36(1):61\u20133.","journal-title":"Int J Dermatol"},{"issue":"5","key":"602_CR70","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jaad.2005.07.026","volume":"53","author":"A Shani-Adir","year":"2005","unstructured":"Shani-Adir A, Kamil S, Rozenman D, et al. Leishmania tropica in northern Israel: a clinical overview of an emerging focus. J Am Acad Dermatol. 2005;53(5):810\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"602_CR71","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/cid\/ciy619","volume":"68","author":"J Soto","year":"2019","unstructured":"Soto J, Soto P, Ajata A, et al. Topical 15% paromomycin-aquaphilic for Bolivian Leishmania braziliensis cutaneous leishmaniasis: a randomized, placebo-controlled trial. Clin Infect Dis. 2019;68(5):844\u20139.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"602_CR72","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4269\/ajtmh.2002.66.147","volume":"66","author":"JM Soto","year":"2002","unstructured":"Soto JM, Toledo JT, Gutierrez P, et al. Treatment of cutaneous leishmaniasis with a topical antileishhmanial drug (WR279396): phase 2 pilot study. Am J Trop Med Hyg. 2002;66(2):147\u201351.","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"602_CR73","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJMoa1202657","volume":"368","author":"A Ben Salah","year":"2013","unstructured":"Ben Salah A, Ben Messaoud N, Guedri E, et al. Topical paromomycin with or without gentamicin for cutaneous leishmaniasis. N Engl J Med. 2013;368(6):524\u201332.","journal-title":"N Engl J Med"},{"issue":"4","key":"602_CR74","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2165\/00003495-199855040-00008","volume":"55","author":"AJ Coukell","year":"1998","unstructured":"Coukell AJ, Brogden RN. Liposomal amphotericin\u00a0B: therapeutic use in the management of fungal infections and visceral leishmaniasis. Drugs. 1998;55(4):585\u2013612.","journal-title":"Drugs"},{"key":"602_CR75","first-page":"11","volume":"10","author":"MR Shirzadi","year":"2019","unstructured":"Shirzadi MR. Lipsosomal amphotericin\u00a0B: a review of its properties, function, and use for treatment of cutaneous leishmaniasis. Res Rep Trop Med. 2019;10:11\u20138.","journal-title":"Res Rep Trop Med"},{"issue":"8","key":"602_CR76","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1468-3083.2010.03908.x","volume":"25","author":"M Solomon","year":"2011","unstructured":"Solomon M, Pavlotsky F, Leshem E, Ephros M, Trau H, Schwartz E. Liposomal amphotericin\u00a0B treatment of cutaneous leishmaniasis due to Leishmania tropica. J Eur Acad Dermatol Venereol. 2011;25(8):973\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"602_CR77","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jaad.2012.06.014","volume":"68","author":"M Solomon","year":"2013","unstructured":"Solomon M, Pavlotzky F, Barzilai A, Schwartz E. Liposomal amphotericin\u00a0B in comparison to sodium stibogluconate for Leishmania braziliensis cutaneous leishmaniasis in travelers. J Am Acad Dermatol. 2013;68(2):284\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"602_CR78","doi-asserted-by":"crossref","first-page":"692","DOI":"10.4269\/ajtmh.2011.10-0712","volume":"84","author":"P Zanger","year":"2011","unstructured":"Zanger P, K\u00f6tter I, Raible A, Gelanew T, Sch\u00f6nian G, Kremsner PG. Case report: successful treatment of cutaneous leishmaniasis caused by Leishmania aethiopica with liposomal amphothericin B in an immunocompromised traveler returning from Eritrea. Am J Trop Med Hyg. 2011;84(5):692\u20134.","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"602_CR79","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1468-3083.2011.04070.x","volume":"26","author":"JOC Motta","year":"2012","unstructured":"Motta JOC, Sampaio RNR. A pilot study comparing low-dose liposomal amphotericin\u00a0B with N-methyl glucamine for the treatment of American cutaneous leishmaniasis. J Eur Acad Dermatol Venereol. 2012;26(3):331\u20135.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"602_CR80","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0001-706X(01)00197-8","volume":"81","author":"P Escobar","year":"2002","unstructured":"Escobar P, Matu S, Marques C, Croft SL. Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH3 (edelfosine) and amphotericin\u00a0B. Acta Trop. 2002;81(2):151\u20137.","journal-title":"Acta Trop"},{"issue":"1","key":"602_CR81","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/INF.0b013e31822dfbf7","volume":"31","author":"JA Herv\u00e1s","year":"2012","unstructured":"Herv\u00e1s JA, Mart\u00edn-Santiago A, Herv\u00e1s D, et al. Old world: Leishmania infantum cutaneous leishmaniasis unresponsive to liposomal amphotericin\u00a0B treated with topical imiquimod. Pediatr Infect Dis J. 2012;31(1):97\u2013100.","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"602_CR82","doi-asserted-by":"crossref","first-page":"e0006094","DOI":"10.1371\/journal.pntd.0006094","volume":"11","author":"R Guery","year":"2017","unstructured":"Guery R, Henry B, Martin-Blondel G, et al. Liposomal amphotericin\u00a0B in travelers with cutaneous and muco-cutaneous leishmaniasis: not a panacea. PLoS Negl Trop Dis. 2017;11(11):e0006094.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"602_CR83","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1042\/bj3150631","volume":"315","author":"M Basselin","year":"1996","unstructured":"Basselin M, Lawrence F, Robert-Gero M. Pentamidine uptake in Leishmania donovani and Leishmania amazonensis promastigotes and axenic amastigotes. Biochem J. 1996;315(2):631\u20134.","journal-title":"Biochem J"},{"issue":"6","key":"602_CR84","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1590\/S0365-05962011000600005","volume":"86","author":"LO Neves","year":"2011","unstructured":"Neves LO, Talhari AC, Gadelha EPN, et al. Estudo cl\u00ednico randomizado comparando antimoniato de meglumina, pentamidina e anfotericina B para o tratamento da leishmaniose cut\u00e2nea ocasionada por Leishmania guyanensis. An Bras Dermatol. 2011;86(6):1092\u2013101.","journal-title":"An Bras Dermatol"},{"issue":"4","key":"602_CR85","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1179\/136485906X105561","volume":"100","author":"M Roussel","year":"2006","unstructured":"Roussel M, Nacher M, Fr\u00e9mont G, et al. Comparison between one and two injections of pentamidine isethionate, at 7 mg\/kg in each injection, in the treatment of cutaneous leishmaniasis in French Guiana. Ann Trop Med Parasitol. 2006;100(4):307\u201314.","journal-title":"Ann Trop Med Parasitol"},{"issue":"1","key":"602_CR86","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4269\/ajtmh.1994.50.107","volume":"50","author":"J Soto","year":"1994","unstructured":"Soto J, Buffet P, Grogl M, Berman J. Successful treatment of Colombian cutaneous leishmaniasis with four injections of pentamidine. Am J Trop Med Hyg. 1994;50(1):107\u201311.","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"602_CR87","doi-asserted-by":"crossref","first-page":"e0006850","DOI":"10.1371\/journal.pntd.0006850","volume":"12","author":"EPN Gadelha","year":"2018","unstructured":"Gadelha EPN, Ramasawmy R, da Costa OB, et al. An open label randomized clinical trial comparing the safety and effectiveness of one, two or three weekly pentamidine isethionate doses (seven milligrams per kilogram) in the treatment of cutaneous leishmaniasis in the Amazon Region. PLoS Negl Trop Dis. 2018;12(10):e0006850.","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"602_CR88","doi-asserted-by":"crossref","first-page":"852","DOI":"10.4269\/ajtmh.15-0640","volume":"94","author":"J Soto","year":"2016","unstructured":"Soto J, Paz D, Rivero D, et al. Intralesional pentamidine: a novel therapy for single lesions of Bolivian cutaneous leishmaniasis. Am J Trop Med Hyg. 2016;94(4):852\u20136.","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"602_CR89","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1365-4362.2002.01633.x","volume":"41","author":"EJSK Lai A Fat","year":"2002","unstructured":"Lai A Fat EJSK, Vrede MA, Soetosenojo RM, Lai A Fat RFM. Pentamidine, the drug of choice for the treatment of cutaneous leishmaniasis in Surinam. Int J Dermatol. 2002;41(11):796\u2013800.","journal-title":"Int J Dermatol"},{"issue":"5","key":"602_CR90","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/jac\/dkg195","volume":"51","author":"P Delobel","year":"2003","unstructured":"Delobel P, Pradinaud R. Rhabdomyolysis associated with pentamidine isethionate therapy for American cutaneous leishmaniasis. J Antimicrob Chemother. 2003;51(5):1319\u201320.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"602_CR91","first-page":"50","volume":"129","author":"A Lieber-Mbomeyo","year":"2002","unstructured":"Lieber-Mbomeyo A, Lipsker D, Mil\u00e9a M, Heid E. Rhabdomyolyse induite par l\u2019is\u00e9thionate de pentamidine (Pentacarinat\u00ae) lors du traitement d\u2019une leishmaniose cutan\u00e9e: 2 cas. Ann Dermatol Venereol. 2002;129(1):50\u20132.","journal-title":"Ann Dermatol Venereol"},{"key":"602_CR92","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.actatropica.2016.12.027","volume":"167","author":"A Shokri","year":"2017","unstructured":"Shokri A, Emami S, Fakhar M, Teshnizi SH, Keighobadi M. In vitro antileishmanial activity of novel azoles (3-imidazolylflavanones) against promastigote and amastigote stages of Leishmania major. Acta Trop. 2017;167:73\u20138.","journal-title":"Acta Trop"},{"issue":"2","key":"602_CR93","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0166-6851(88)90166-1","volume":"31","author":"DH Beach","year":"1988","unstructured":"Beach DH, Goad LJ, Holz GG. Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes. Mol Biochem Parasitol. 1988;31(2):149\u201362.","journal-title":"Mol Biochem Parasitol"},{"issue":"1","key":"602_CR94","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/cid\/ciw662","volume":"64","author":"FVO De Prates","year":"2017","unstructured":"De Prates FVO, Dourado MEF, Silva SC, et al. Fluconazole in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis: a randomized controlled trial. Clin Infect Dis. 2017;64(1):67\u201371.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"602_CR95","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa011882","volume":"346","author":"AA Alrajhi","year":"2002","unstructured":"Alrajhi AA, Ibrahim EA, De Vol EB, Khairat M, Faris RM, Maguire JH. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med. 2002;346(12):891\u20135.","journal-title":"N Engl J Med"},{"issue":"5","key":"602_CR96","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF00417211","volume":"275","author":"L Weinrauch","year":"1983","unstructured":"Weinrauch L, Livshin R, Even-Paz Z, El-On J. Efficacy of ketoconazole in cutaneous leishmaniasis. Arch Dermatol Res. 1983;275(5):353\u20134.","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"602_CR97","first-page":"14","volume":"69","author":"A Abahusein","year":"1992","unstructured":"Abahusein A, Larbi EB, Al-Khawajah A, Al-Gindan Y, Jain S. Evaluation of topical ketoconazole in cutaneous leishmaniasis. East Afr Med J. 1992;69(1):14\u20137.","journal-title":"East Afr Med J"},{"issue":"5","key":"602_CR98","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/clinids\/18.5.813","volume":"18","author":"KF Baum","year":"1994","unstructured":"Baum KF, Berens RL. Successful treatment of cutaneous leishmaniasis with allopurinol after failure of treatment with ketoconazole. Clin Infect Dis. 1994;18(5):813\u20135.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"602_CR99","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/09546630305552","volume":"14","author":"AZ Momeni","year":"2003","unstructured":"Momeni AZ, Aminjavaheri M, Omidghaemi MR. Treatment of cutaneous leishmaniasis with ketoconazole cream. J Dermatolog Treat. 2003;14(1):26\u20139.","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"602_CR100","doi-asserted-by":"crossref","first-page":"476","DOI":"10.17843\/rpmesp.2018.353.3531","volume":"35","author":"AM Vera","year":"2018","unstructured":"Vera AM, Casadiego OA, Mantilla JC, Escobar P. Evaluation of ketoconazole formulations for topical use in cutaneous leishmaniasis caused by Leishmania (Viannia). Rev Peru Med Exp Salud Publica. 2018;35(3):476\u201382.","journal-title":"Rev Peru Med Exp Salud Publica"},{"issue":"12","key":"602_CR101","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0020-7519(96)00128-2","volume":"26","author":"J Dogra","year":"1996","unstructured":"Dogra J, Saxena VN. Itraconazole and leishmaniasis: a randomised double-blind trial in cutaneous disease. Int J Parasitol. 1996;26(12):1413\u20135.","journal-title":"Int J Parasitol"},{"issue":"9","key":"602_CR102","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-4362.1990.tb02593.x","volume":"29","author":"J Dogra","year":"1990","unstructured":"Dogra J, Aneja N, Lal BB, Mishra SN. Cutaneous leishmaniasis in India: clinical experience with itraconazole (R51 211 Janssen). Int J Dermatol. 1990;29(9):661\u20132.","journal-title":"Int J Dermatol"},{"issue":"8","key":"602_CR103","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/00034983.2000.11813603","volume":"94","author":"A Zakai","year":"2000","unstructured":"Zakai A, Zimmo H. Effects of itraconazole and terbinafine on Leishmania major lesions in BALB\/c mice. Ann Trop Med Parasitol. 2000;94(8):787\u201391.","journal-title":"Ann Trop Med Parasitol"},{"issue":"7","key":"602_CR104","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archderm.1996.03890310070009","volume":"132","author":"AZ Momeni","year":"1996","unstructured":"Momeni AZ. Treatment of cutaneous leishmaniasis with itraconazole. Arch Dermatol. 1996;132(7):784.","journal-title":"Arch Dermatol"},{"issue":"1","key":"602_CR105","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1468-3083.2004.01133.x","volume":"19","author":"M Nassiri-Kashani","year":"2005","unstructured":"Nassiri-Kashani M, Firooz A, Khamesipour A, et al. A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis. J Eur Acad Dermatol Venereol. 2005;19(1):80\u20133.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"602_CR106","doi-asserted-by":"crossref","first-page":"562","DOI":"10.4103\/1995-7645.244516","volume":"11","author":"A Oryan","year":"2018","unstructured":"Oryan A, Bahrami S, Bemani E. Efficacy of voriconazole on leishmaniasis by Leishmania major: an in vitro and in vivo study. Asian Pac J Trop Med. 2018;11(10):562\u20139.","journal-title":"Asian Pac J Trop Med"},{"key":"602_CR107","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jgar.2018.05.007","volume":"14","author":"A Shokri","year":"2018","unstructured":"Shokri A, Abastabar M, Keighobadi M, et al. Promising antileishmanial activity of novel imidazole antifungal drug luliconazole against Leishmania major: in vitro and in silico studies. J Glob Antimicrob Resist. 2018;14:260\u20135.","journal-title":"J Glob Antimicrob Resist"},{"issue":"9","key":"602_CR108","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1365-4632.2005.02628.x","volume":"44","author":"A Panagiotopoulos","year":"2005","unstructured":"Panagiotopoulos A, Stavropoulos PG, Hasapi V, Papakonstantinou AM, Petridis A, Katsambas A. Treatment of cutaneous leishmaniasis with cryosurgery. Int J Dermatol. 2005;44(9):749\u201352.","journal-title":"Int J Dermatol"},{"issue":"4","key":"602_CR109","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-4632.2004.02002.x","volume":"43","author":"A Asilian","year":"2004","unstructured":"Asilian A, Sadeghinia A, Faghihi G, Momeni A. Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime\u00ae) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime\u00ae) alone for the treatment of cutaneous leishmaniasis. Int J Dermatol. 2004;43(4):281\u20133.","journal-title":"Int J Dermatol"},{"issue":"9","key":"602_CR110","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/cid\/cit049","volume":"56","author":"J Soto","year":"2013","unstructured":"Soto J, Rojas E, Guzman M, et al. Intralesional antimony for single lesions of Bolivian cutaneous Leishmaniasis. Clin Infect Dis. 2013;56(9):1255\u201360.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"602_CR111","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.trstmh.2012.02.006","volume":"106","author":"E Negera","year":"2012","unstructured":"Negera E, Gadisa E, Hussein J, et al. Treatment response of cutaneous leishmaniasis due to Leishmania aethiopica to cryotherapy and generic sodium stibogluconate from patients in Silti, Ethiopia. Trans R Soc Trop Med Hyg. 2012;106(8):496\u2013503.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"602_CR112","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/09546631003762654","volume":"22","author":"RR Ranawaka","year":"2011","unstructured":"Ranawaka RR, Weerakoon HS, Opathella N. Liquid nitrogen cryotherapy on Leishmania donovani cutaneous leishmaniasis. J Dermatol Treat. 2011;22(4):241\u20135.","journal-title":"J Dermatol Treat"},{"key":"602_CR113","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12879-016-1663-3","volume":"16","author":"L L\u00f3pez-Carvajal","year":"2016","unstructured":"L\u00f3pez-Carvajal L, Cardona-Arias JA, Zapata-Cardona MI, S\u00e1nchez-Giraldo V, V\u00e9lez ID. Efficacy of cryotherapy for the treatment of cutaneous leishmaniasis: meta-analyses of clinical trials. BMC Infect Dis. 2016;16:360.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"602_CR114","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.4269\/ajtmh.16-0879","volume":"97","author":"WF Refai","year":"2017","unstructured":"Refai WF, Madarasingha NP, Sumanasena B, et al. Efficacy, safety and cost-effectiveness of thermotherapy in the treatment of Leishmania donovani-induced cutaneous leishmaniasis: a randomized controlled clinical trial. Am J Trop Med Hyg. 2017;97(4):1120\u20136.","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"602_CR115","doi-asserted-by":"crossref","first-page":"345","DOI":"10.7205\/MILMED-D-11-00161","volume":"177","author":"N Safi","year":"2012","unstructured":"Safi N, Davis GD, Nadir M, Hamid H, Robert LL, Case AJ. Evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Kabul, Afghanistan: a randomized controlled trial. Mil Med. 2012;177(3):345\u201351.","journal-title":"Mil Med"},{"issue":"2","key":"602_CR116","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4269\/ajtmh.1981.30.318","volume":"30","author":"JD Berman","year":"1981","unstructured":"Berman JD, Neva FA. Effect of temperature on multiplication of Leishmania amastigotes within human monocyte-derived macrophages in vitro. Am J Trop Med Hyg. 1981;30(2):318\u201321.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"602_CR117","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4269\/ajtmh.1983.32.300","volume":"32","author":"DL Sacks","year":"1983","unstructured":"Sacks DL, Barral A, Neva FA. Thermosensitivity patterns of Old vs. New World cutaneous strains of Leishmania growing within mouse peritoneal macrophages in vitro. Am J Trop Med Hyg. 1983;32(2):300\u20134.","journal-title":"Am J Trop Med Hyg."},{"issue":"10","key":"602_CR118","doi-asserted-by":"publisher","first-page":"e0004178","DOI":"10.1371\/journal.pntd.0004178","volume":"9","author":"I Lakhal-Naouar","year":"2015","unstructured":"Lakhal-Naouar I, Slike BM, Aronson NE, Marovich MA. The immunology of a healing response in cutaneous leishmaniasis treated with localized heat or systemic antimonial therapy. PLoS Negl Trop Dis. 2015;9(10):e0004178. https:\/\/doi.org\/10.1371\/journal.pntd.0004178.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"602_CR119","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/jrms.JRMS_934_19","volume":"26","author":"A Siadat","year":"2021","unstructured":"Siadat A, Iraji F, Zolfaghari A, Shariat S, Jazi S. Heat therapy for cutaneous leishmaniasis: a literature review. J Res Med Sci. 2021;26(1):15.","journal-title":"J Res Med Sci"},{"issue":"4","key":"602_CR120","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2230.2007.02405.x","volume":"32","author":"G Sadeghian","year":"2007","unstructured":"Sadeghian G, Nilfroushzadeh MA, Iraji F. Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate. Clin Exp Dermatol. 2007;32(4):371\u20134.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"602_CR121","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4269\/ajtmh.1990.42.43","volume":"42","author":"TR Navin","year":"1990","unstructured":"Navin TR, Arana BA, Arana FE, De Merida AM, Castillo AL, Pozuelos JL. Placebo-controlled clinical trial of meglumine antimonate (Glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala. Am J Trop Med Hyg. 1990;42(1):43\u201350.","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"602_CR122","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1590\/S0036-46652013000300011","volume":"55","author":"L L\u00f3pez","year":"2013","unstructured":"L\u00f3pez L, Cruz C, Godoy G, Robledo SM, V\u00e9lez ID. Termoterapia efectiva y m\u00e1s segura que la miltefosina en el tratamiento de la leishmaniasis cut\u00e1nea en Colombia. Rev Inst Med Trop Sao Paulo. 2013;55(3):197\u2013204.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"5","key":"602_CR123","doi-asserted-by":"crossref","first-page":"e2196","DOI":"10.1371\/journal.pntd.0002196","volume":"7","author":"BM Valencia","year":"2013","unstructured":"Valencia BM, Miller D, Witzig RS, Boggild AK, Llanos-Cuentas A. Novel low-cost thermotherapy for cutaneous leishmaniasis in Peru. PLoS Negl Trop Dis. 2013;7(5):e2196.","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"602_CR124","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4269\/ajtmh.1997.57.309","volume":"57","author":"O Velasco-Castrejon","year":"1997","unstructured":"Velasco-Castrejon O, Walton BC, Rivas-Sanchez B, et al. Treatment of cutaneous leishmaniasis with localized current field (radio frequency) in Tabasco, Mexico. Am J Trop Med Hyg. 1997;57(3):309\u201312.","journal-title":"Am J Trop Med Hyg"},{"issue":"7","key":"602_CR125","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-4362.2002.01527.x","volume":"41","author":"AZ Momeni","year":"2002","unstructured":"Momeni AZ, Reiszadae MR, Aminjavaheri M. Treatment of cutaneous leishmaniasis with a combination of allopurinol and low-dose meglumine antimoniate. Int J Dermatol. 2002;41(7):441\u20133.","journal-title":"Int J Dermatol"},{"key":"602_CR126","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijpddr.2019.08.002","volume":"10","author":"LF Gon\u00e7alves-Oliveira","year":"2019","unstructured":"Gon\u00e7alves-Oliveira LF, Souza-Silva F, de Castro C\u00f4rtes LM, et al. The combination therapy of meglumine antimoniate and oxiranes (epoxy-\u03b1-lapachone and epoxymethyl-lawsone) enhance the leishmanicidal effect in mice infected by Leishmania (Leishmania) amazonensis. Int J Parasitol Drugs Drug Resist. 2019;10:101\u20138.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"5","key":"602_CR127","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1179\/000349803225001373","volume":"97","author":"A Asilian","year":"2003","unstructured":"Asilian A, Sadeghinia A, Faghihi G, Momeni A, Amini HA. The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis. Ann Trop Med Parasitol. 2003;97(5):493\u20138.","journal-title":"Ann Trop Med Parasitol"},{"issue":"8","key":"602_CR128","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1365-4362.2002.01526.x","volume":"41","author":"I Esfandiarpour","year":"2002","unstructured":"Esfandiarpour I, Alavi A. Evaluating the efficacy of allopurinol and meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis. Int J Dermatol. 2002;41(8):521\u20134.","journal-title":"Int J Dermatol"},{"issue":"2","key":"602_CR129","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/clinids\/24.2.165","volume":"24","author":"S Martinez","year":"1997","unstructured":"Martinez S, Gonzalez M, Vernaza ME. Treatment of cutaneous leishmaniasis with allopurinol and stibogluconate. Clin Infect Dis. 1997;24(2):165\u20139.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"602_CR130","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0169-4758(93)90231-4","volume":"9","author":"PL Olliaro","year":"1993","unstructured":"Olliaro PL, Bryceson ADM. Practical progress and new drugs for changing patterns of leishmaniasis. Parasitol Today. 1993;9(9):323\u20138.","journal-title":"Parasitol Today"},{"issue":"9","key":"602_CR131","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1365-4632.2006.02822.x","volume":"45","author":"R Salmanpour","year":"2006","unstructured":"Salmanpour R, Razmavar MR, Abtahi N. Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis. Int J Dermatol. 2006;45(9):1115\u20136.","journal-title":"Int J Dermatol"},{"issue":"3","key":"602_CR132","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1468-3083.2009.03417.x","volume":"24","author":"M El-Sayed","year":"2010","unstructured":"El-Sayed M, Anwar A. Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study. J Eur Acad Dermatol Venereol. 2010;24(3):335\u201340.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"602_CR133","doi-asserted-by":"crossref","first-page":"e2832","DOI":"10.1371\/journal.pntd.0002832","volume":"8","author":"CJ Hodiamont","year":"2014","unstructured":"Hodiamont CJ, Kager PA, Bart A, et al. Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guide. PLoS Negl Trop Dis. 2014;8(5):e2832.","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"602_CR134","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.4269\/ajtmh.2010.10-0143","volume":"83","author":"PP Van Thiel","year":"2010","unstructured":"Van Thiel PP, Leenstra T, De Vries HJ, et al. Cutaneous leishmaniasis (Leishmania major infection) in Dutch troops deployed in Northern Afghanistan: Epidemiology, clinical aspects, and treatment. Am J Trop Med Hyg. 2010;83(6):1295\u2013300.","journal-title":"Am J Trop Med Hyg"},{"key":"602_CR135","doi-asserted-by":"crossref","unstructured":"Jaffary F, Nilforoushzadeh MA, Siadat A, Haftbaradaran E, Ansari N, Ahmadi E. A comparison between the effects of glucantime, topical trichloroacetic acid 50% plus glucantime, and fractional carbon dioxide laser plus glucantime on cutaneous leishmaniasis lesions. Dermatol Res Pract. 2016;2016:6462804.","DOI":"10.1155\/2016\/6462804"},{"issue":"12","key":"602_CR136","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1371\/journal.pntd.0001974","volume":"6","author":"R Garc\u00eda-Hern\u00e1ndez","year":"2012","unstructured":"Garc\u00eda-Hern\u00e1ndez R, Manzano JI, Castanys S, Gamarro F. Leishmania donovani develops resistance to drug combinations. PLoS Negl Trop Dis. 2012;6(12):1974.","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-022-00602-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-022-00602-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-022-00602-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T15:39:29Z","timestamp":1648481969000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-022-00602-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,22]]},"references-count":136,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["602"],"URL":"https:\/\/doi.org\/10.1007\/s40121-022-00602-2","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,22]]},"assertion":[{"value":"8 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}